METOCLOPRAMIDE 10 MG/2 ML VIAL

What it is

METOCLOPRAMIDE 10 MG/2 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “metoclopramide” and “metoclopramide hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “injection, solution” and “injection” and its route as intramuscular; intravenous.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Hospira, Inc., Teva Parenteral Medicines, Inc. and Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

FDA’s Established Pharmacologic Class for it is Dopamine-2 Receptor Antagonist.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.06 for 2 mL (2 × $0.52896 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-07-22. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.

The NADAC of all 5 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-07-22. The file is new; the price is not.

What NADAC measures · NADAC explanation codes · Carried-forward prices

All 5 NDCs

• 00409-3414-11 · Hospira, Inc. · $0.52896 per ML · eff. 2026-07-22 filed carried forward
• 00409-5255-15 · Hospira, Inc. · $0.52896 per ML · eff. 2026-07-22 filed carried forward
• 00703-4502-04 · Teva Parenteral Medicines, Inc. · $0.52896 per ML · eff. 2026-07-22 filed carried forward
• 23155-0240-41 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.52896 per ML · eff. 2026-07-22 filed carried forward
• 83634-0779-02 · Avenacy, LLC · $0.52896 per ML · eff. 2026-07-22 filed carried forward

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with METOCLOPRAMIDE 10 MG/2 ML VIAL.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

What Medicare paid

Medicare Part B’s payment limit for HCPCS J2765, for 2026-10-01 to 2026-12-31, comes to $0.89 for 2 mL, or $0.4455 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.1782 per 10 MG.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 2 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 2 mL; your package may hold a different amount.
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.